Company

HBM Partners is among the global leaders in healthcare-focused investing with USD 1 billion under management. HBM focuses on development stage, growth and buy-out financings of private companies as well as investments in public companies.

Company
Company
 

Company

HBM Partners is among the global leaders in healthcare-focused investing with USD 1 billion under management. HBM focuses on development stage, growth and buy-out financings of private companies as well as investments in public companies.

Company
 

Investment Products

HBM Partners advises HBM Healthcare Investments and healthcare related public and private equity funds.

Investment Portfolio
Investment Portfolio
 

Investment Products

HBM Partners advises HBM Healthcare Investments and healthcare related public and private equity funds.

Investment Portfolio
 

Portfolio

HBM Partners actively supports a portfolio of some 40 growth companies
focusing on value creation from innovative technologies and novel products

Portfolio
Portfolio
 

Portfolio

HBM Partners actively supports a portfolio of some 40 growth companies
focusing on value creation from innovative technologies and novel products

Portfolio
 

Portfolio News

Probiodrug raises €22 5 million in successful Initial Public Offering and listing on Euronext Amsterdam

Portfolio News
Portfolio News
 

Portfolio News

Probiodrug raises €22 5 million in successful Initial Public Offering and listing on Euronext Amsterdam

Portfolio News
 

Industry Reports

HBM Pharma/Biotech M&A Report and HBM New Drug Approval Report

Industry Reports
Industry Reports
 

Industry Reports

HBM Pharma/Biotech M&A Report and HBM New Drug Approval Report

Industry Reports
 
 
 
 
 

© HBM Partners AG